Dassault Systemes SA earnings date
Dassault Systemes SA (DSY) Q3 2026 Earnings Report
DE:DSY Q3 2026 EPS Results
- Actual EPS
- EUR 0.32
- Consensus EPS
- EUR 0.32
- Beat/Miss
- Beat by +EUR 0.01
- One Year Ago EPS
- EUR 0.31
DE:DSY Q3 2026 Revenue Results
- Actual Revenue
- EUR 1.62B
- Expected Revenue
- EUR 1.56B
- Beat/Miss
- Beat by +EUR 63.04M
- YoY Revenue Growth
- +4.64%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 10/28/2026
- Time
- Before Open
- Conference Call
- Wednesday, October 28, 2026
Dassault Systemes SA's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
Q3 2026 Earnings Call Summary
The call was strongly positive, supported by Q3 revenue and EPS growth, margin expansion, strong cash generation, improving recurring-revenue momentum, and raised full-year guidance. Management also reported progress in 3DEXPERIENCE, cloud, China, AI, and Life Sciences. The main challenges were the 3% Americas decline, flat MEDIDATA revenue, softer Central and Southern Europe performance, and remaining work to improve partner-channel execution, integrate ArisGlobal, and scale AI adoption.
For the full year, Dassault Systèmes expects revenue growth of 4% to 5%, versus 3% to 5% previously, with revenue of EUR 6.399 billion to EUR 6.459 billion, operating margin of 32.5% to 32.7% versus 32.2% to 32.6% prior, and EPS growth of 6% to 7% versus 3% to 6% previously, or EPS of EUR 1.35 to EUR 1.36. For the fourth quarter, it expects revenue growth of 5% to 8%, including a 2-point contribution from ArisGlobal, operating margin of 37.2% to 37.8%, and EPS of EUR 0.42 to EUR 0.43, up 3% to 7% ex-FX, based on $1.14 per euro, JPY 170 per euro, and a tax rate of 17.4%; MEDIDATA is expected to return to growth in Q4, with an indication of around 2 plus.
- Strong Q3 ExecutionThird-quarter total revenue grew 5%, software revenue increased 5%, 3DEXPERIENCE revenue rose 25%, cloud revenue grew 14%, and EPS reached EUR 0.32, up 8% ex-FX.
- Raised Full-Year ObjectivesThe company raised its full-year revenue growth outlook to 4% to 5% from 3% to 5%, and increased expected EPS growth to 6% to 7% from 3% to 6%. ArisGlobal is included in the updated outlook.
- Revenue and Profitability Above ExpectationsThird-quarter revenue reached EUR 1.552 billion, at the top end of expectations. Operating margin expanded by 150 basis points to 31.6%, operating profit rose 10% year-on-year, and EPS grew 8% ex-FX.
- Strong Year-to-Date Cash GenerationYear-to-date operating cash flow reached EUR 1.567 billion, up 20% ex-FX and 18% as reported. Free cash flow increased 25% ex-FX to EUR 1.388 billion, cash conversion reached 111%, and third-quarter operating cash flow was up over 77%.
- Recurring Revenue and Subscription TransitionARR increased 6% to EUR 4.505 billion after the addition of EUR 62 million in annualized contract value compared with Q2. Subscription revenue grew 6%, subscription ARR was growing at a low to mid-teens rate approaching mid-teens, and subscription represented 50% of recurring revenue, up from 46% in Q3 of the prior year.
- Growth in Subscription, License, and Services RevenueSubscription revenue grew 6%, licenses increased 14%, and services revenue rose 7%. The license growth mainly reflected robust performance in China and a low comparison baseline from the prior year.
- Strong Performance in 3DEXPERIENCE and Cloud3DEXPERIENCE revenue increased 25%, cloud revenue grew 14%, and 3DEXPERIENCE Cloud grew 46%. The company attributed the performance to customers transforming operations and preparing for industrial AI at scale.
- Asia and Europe GrowthAsia grew 12%, supported by broad-based regional performance and an excellent performance in China. Europe grew 9%, driven by renewals in the U.K. and France.
- China Momentum and COMAC EngagementThe company reported strong momentum in China across high-tech, industrial equipment, and automotive, along with good aerospace momentum including a COMAC deal and important high-tech wins. Dassault Systèmes is providing COMAC with a unified environment spanning design, systems engineering, simulation, and manufacturing planning.
- Industrial Innovation and Mainstream Innovation GrowthIndustrial Innovation grew 5% despite a strong comparison base, with 3DEXPERIENCE Cloud and ENOVIA leading momentum. Mainstream Innovation increased 8%, supported by CENTRIC and SOLIDWORKS.
- SOLIDWORKS and CENTRIC MomentumSOLIDWORKS unit growth was up double digit across geographies, with more than 40 AI use cases supporting the move to subscription from CATIA to simulation and manufacturing. CENTRIC delivered another strong quarter with significant wins in sports merchandising and licensing and with a U.S. fashion and outdoor brand.
- Improvement in Life SciencesThe Life Sciences product line grew 1%. MEDIDATA improved sequentially and was flat year-over-year, while Patient Cloud and study experience were identified as the fastest-growing solution categories. The company also reported expanding its pipeline of transformational platform agreements.
- ArisGlobal Acquisition CompletedDassault Systèmes completed the EUR 1.5 billion ArisGlobal acquisition in the second half of September. ArisGlobal revenue was not material in Q3, and the acquisition is intended to connect drug safety and the broader pharmaceutical journey on one AI-native platform.
- AI-Native Platform AdoptionThe company has engaged around 100 strategic customer partnerships to develop and fine-tune agentic platform use cases. It plans to move from promising use cases to solutions deployed more broadly and repeatedly beginning in 2027.
- AI Applications in Engineering and ManufacturingExamples with Volkswagen, Agile Robots, and Audi demonstrated virtual companions coordinating engineering work, using specialized engineering expertise, and enabling teams to test robot scenarios, safety, cycle times, and production throughput in virtual environments before deployment.
- AI Infrastructure OpportunityDiversification industries grew at a double-digit rate, with particularly strong momentum in high-tech around AI infrastructure. The company is working with Vertiv on an integrated solution covering AI-factory design and simulation, including compute, networking, power, cooling, and software.
- Improved Full-Year Margin and EPS GuidanceFull-year operating margin guidance was raised to 32.5% to 32.7% from 32.2% to 32.6%. EPS guidance was increased to EUR 1.35 to EUR 1.36, representing 6% to 7% growth versus the previous 3% to 6% outlook.
- Q4 Outlook and Financial FlexibilityThe company expects Q4 revenue growth of 5% to 8%, including a 2-point contribution from ArisGlobal, operating margin of 37.2% to 37.8%, and EPS of EUR 0.42 to EUR 0.43, up 3% to 7% ex-FX. Net cash was EUR 1.049 billion after funding the ArisGlobal acquisition and repaying a EUR 0.9 billion bond.
- New Life Sciences Leadership and Operating ModelDr. Ashwini Zenooz joined as Executive Vice President and CEO of Life Sciences & Healthcare. The company is bringing Medidata, BIOVIA, and ArisGlobal together under a coordinated organization focused on connecting molecules, patients, and real-world outcomes.
DE:DSY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 0.44- | 0.43 | ― | ― |
| Oct 28, 2026 | 2026 (Q3) | 0.320.32 | 0.31 | 5.64% (+0.02) | |
| Jul 23, 2026 | 2026 (Q2) | 0.310.32 | 0.32 | 0.00% (+0.00) | |
| Apr 23, 2026 | 2026 (Q1) | 0.320.32 | 0.33 | -3.57% (-0.01) | |
| Feb 11, 2026 | 2025 (Q4) | 0.440.43 | 0.38 | 14.22% (+0.05) | |
| Oct 23, 2025 | 2025 (Q3) | 0.310.31 | 0.28 | 7.67% (+0.02) | |
| Jul 24, 2025 | 2025 (Q2) | 0.320.32 | 0.3 | 8.28% (+0.02) | |
| Apr 24, 2025 | 2025 (Q1) | 0.320.33 | 0.29 | 13.40% (+0.04) | |
| Feb 04, 2025 | 2024 (Q4) | 0.370.38 | 0.35 | 6.41% (+0.02) | |
| Oct 24, 2024 | 2024 (Q3) | 0.280.28 | 0.27 | 5.74% (+0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.


